118 related articles for article (PubMed ID: 21029604)
1. [Spontaneous clearance of high risk human papillomavirus infection].
Zhang WY; Ma CB; Xiao JY; Zhou HR
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):515-8. PubMed ID: 21029604
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
3. [HPV infection of the cervix and capabilities of advanced diagnostics].
Akush Ginekol (Sofiia); 2010; 49(3):40-3. PubMed ID: 20734655
[TBL] [Abstract][Full Text] [Related]
4. Patterns of genotype distribution in multiple human papillomavirus infections.
Oliveira LH; Rosa ML; Cavalcanti SM
Clin Microbiol Infect; 2008 Jan; 14(1):60-5. PubMed ID: 18154550
[TBL] [Abstract][Full Text] [Related]
5. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
[TBL] [Abstract][Full Text] [Related]
6. Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array.
de Antonio JC; Fernández-Olmos A; Mercadillo M; Lindemann ML; Mochales FB
J Virol Methods; 2008 Apr; 149(1):163-6. PubMed ID: 18328575
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
9. [The morphological characteristics of a papillomavirus infection in the epithelial tissue of the cervix uteri in comparison with the data from the molecular biological identification of specific HPV DNA sequences].
Isakova LM; Ganina KP; Ivanova IM; Vakulenko GA
Tsitol Genet; 1998; 32(1):55-65. PubMed ID: 9695253
[TBL] [Abstract][Full Text] [Related]
10. Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women.
Chabaud M; Le Cann P; Mayelo V; Leboulleux D; Diallo AS; Enogat N; Afoutou JM; Anthonioz P; Coll-Seck AM; Coursaget P
J Med Virol; 1996 Aug; 49(4):259-63. PubMed ID: 8877756
[TBL] [Abstract][Full Text] [Related]
11. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
[TBL] [Abstract][Full Text] [Related]
12. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.
Muñoz N; Méndez F; Posso H; Molano M; van den Brule AJ; Ronderos M; Meijer C; Muñoz A;
J Infect Dis; 2004 Dec; 190(12):2077-87. PubMed ID: 15551205
[TBL] [Abstract][Full Text] [Related]
13. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
Perrons C; Brink N; Jalal H; Watts P; Jelley R
J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
15. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.
Bruni L; Diaz M; Castellsagué X; Ferrer E; Bosch FX; de Sanjosé S
J Infect Dis; 2010 Dec; 202(12):1789-99. PubMed ID: 21067372
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of HPV-related diseases: cervical cancer and genital warts.
Brotzman GL
J Fam Pract; 2005 Jul; Suppl HPV Prevention():S3-9; quiz S23. PubMed ID: 16093010
[No Abstract] [Full Text] [Related]
17. [Clinical evaluation of the xMAP technology in detection of high-risk human papillomavirus].
Liao GD; Zhang XY; Gao YH; Liu B; Liu X; Li LK; Chen F; Bian ML; Chen W; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):603-7. PubMed ID: 18051713
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
Schiffman M; Wheeler CM; Castle PE;
J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Ning L; Killeen J; Kamemoto L; Hernandez BY
J Infect Dis; 2008 Apr; 197(7):957-66. PubMed ID: 18429348
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]